Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 7.99
-0.15 (-1.84%)
Sep 11, 2026, 3:04 PM CST
SHE:300009 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,452 | 2,647 | 2,536 | 2,866 | 2,331 | 2,169 |
Revenue Growth | -3.05% | 4.36% | -11.51% | 22.94% | 7.48% | 27.47% |
Gross Profit Gross Profit Growth | 1,832 | 1,986 | 1,955 | 2,240 | 1,818 | 1,733 |
Operating Income Operating Income Growth | 758.95 | 800.39 | 759.09 | 912.92 | 755.7 | 599.3 |
Net Income Net Income Growth | 701.01 | 735.19 | 706.95 | 847.23 | 703.26 | 206.63 |
Earnings Per Share EPS Growth | 0.42 | 0.44 | 0.42 | 0.51 | 0.43 | 0.13 |
EPS Growth | 7.23% | 4.76% | -17.03% | 17.72% | 230.77% | -40.91% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Biological Products Biological Products Growth | 1,980 | 1,865 | 2,100 | 1,556 | 1,295 |
Chinese Patent Medicine Chinese Patent Medicine Growth | 289.17 | 298.97 | 358.25 | 404.44 | 518.74 |
Synthetic drugs Synthetic drugs Growth | 150.25 | 151.13 | 178.58 | 147.47 | 134.65 |
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth | 101.58 | 103.24 | 91.77 | 72.35 | 62.56 |
Technical Services Technical Services Growth | 24.73 | 31.62 | 58.34 | 76.39 | 94.64 |
Others Others Growth | 100.88 | 85.69 | 79.04 | 74.22 | 54.53 |
Total Total Growth | 2,647 | 2,536 | 2,866 | 2,331 | 2,160 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,432 | 1,583 | 1,444 | 1,456 | 1,167 | 1,128 |
Total Debt Total Debt Growth | 98.6 | 32.96 | 53.96 | 56.63 | 33.14 | 27.04 |
Net Cash (Debt) Net Cash Growth | 1,333 | 1,550 | 1,390 | 1,399 | 1,134 | 1,101 |
Net Cash Growth | 14.19% | 11.54% | -0.66% | 23.35% | 3.03% | 25.04% |
Net Cash Per Share Net Cash Per Share Growth | 0.80 | 0.93 | 0.83 | 0.84 | 0.69 | 0.69 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 819.29 | 863.22 | 685.37 | 952.97 | 698.98 | 592.17 |
Capital Expenditures CapEx Growth | -137.72 | -126.89 | -117.22 | -195.34 | -474.34 | -131.23 |
Free Cash Flow Free Cash Flow Growth | 681.57 | 736.33 | 568.15 | 757.64 | 224.64 | 460.94 |
Free Cash Flow Growth | -4.99% | 29.60% | -25.01% | 237.27% | -51.27% | 41.27% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.72% | 75.04% | 77.08% | 78.15% | 77.97% | 79.89% |
Operating Margin | 30.95% | 30.24% | 29.93% | 31.86% | 32.42% | 27.63% |
Pretax Margin | 32.28% | 31.48% | 31.66% | 32.10% | 35.77% | 13.61% |
Profit Margin | 28.59% | 27.78% | 27.88% | 29.56% | 30.17% | 9.53% |
FCF Margin | 27.79% | 27.82% | 22.40% | 26.44% | 9.64% | 21.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.250 | 0.250 | 0.250 | 0.250 | 0.250 | 0.200 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 25.00% | 19.98% |
Dividend Yield | 2.98% | 2.69% | 3.07% | 2.67% | 2.99% | 1.74% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.38 | 21.72 | 20.39 | 20.18 | 22.21 | 103.80 |
Forward PE | 17.32 | 14.16 | 14.16 | 17.47 | 21.27 | 35.62 |
P/FCF Ratio | 19.91 | 21.68 | 25.37 | 22.56 | 69.55 | 46.53 |
PS Ratio | 5.53 | 6.03 | 5.68 | 5.97 | 6.70 | 9.89 |